Hmmmmm, that makes this half about 5 - 6 mil of EBITDA. With an outlook statement suggesting things aren't getting any better.
Could be annualising $10mil of EBITDA with NPAT somewhere around $2 to $4mil. Unlikely there will be a dividend this year.
Not sure what the market has priced in, but this seems worse than what I expected.
- Forums
- ASX - By Stock
- MTO
- Ann: EBITDA Guidance
Ann: EBITDA Guidance, page-4
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MTO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.63 |
Change
0.010(0.62%) |
Mkt cap ! $120.3M |
Open | High | Low | Value | Volume |
$1.62 | $1.66 | $1.62 | $4.935K | 3.029K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 466 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 33 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 466 | 1.630 |
1 | 582 | 1.625 |
2 | 6692 | 1.620 |
1 | 621 | 1.610 |
3 | 65422 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.665 | 33 | 1 |
1.675 | 20000 | 1 |
1.690 | 5700 | 1 |
1.700 | 8593 | 5 |
1.710 | 2500 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
MTO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online